NYU Langone’s Cardiovascular Genetics Program provides comprehensive risk assessment of patients with inherited forms of heart disease, including hypertrophic and dilated cardiomyopathy, long QT syndrome, Brugada syndrome, and other heritable arrhythmic disorders. We offer the most advanced treatment and counseling available for individuals and family members at risk for or already diagnosed with an inherited cardiac condition.
In order to provide patients with the best possible care and recovery outcomes, we are also dedicated to researching the causes and new treatment options for inherited cardiovascular disease through ongoing clinical trials. We collect and record participants’ family history and medical and genetic information, as well as other clinical reports.
Our physician investigators have used this information to create some of the largest databases in the world for inherited cardiac conditions, in order to develop better condition management strategies and to identify the risk for complications associated with disorders that include arrhythmias, or irregular heartbeat, and sudden cardiac death.
You have access to cutting-edge diagnostics and other services available only through the Cardiovascular Genetics Program, including the arrhythmia expertise of NYU Langone’s Heart Rhythm Center and heart failure experts from NYU Langone’s Heart Failure Advanced Care Center team. Together, we translate research directly to bedside care for each and every patient.
If you would like to join a clinical trial screening for new genetic causes and effects of cardiovascular diseases, please call us at 212-263-9136. Please mention that you are interested in participating in ongoing research, so that one of our clinical research scientists can discuss your options with you.